James P.M. Odell, OMD, ND, L.Ac.
Within a year of the WHO’s announced ‘pandemic’, the pharmaceutical industry developed several inoculations for Covid-19, quickly gaining FDA authorization for public emergency use. Recently, the Advisory Committee on Immunization Practices (ACIP) to the CDC endorsed the FDA's full approval of the Pfizer and BioNTech COVID biological mRNA product called 'Comirnaty'. The full approval marks a regulatory switch for Pfizer's inoculation away from an experimental (EUA) therapy. The inoculation 'Comirnaty' is officially approved for Americans over the age of 16, while the EUA remains in effect for patients between 12 and 15. Moderna and Johnson and Johnson are still under EAU. Pfizer-BioNTech is now planning to quickly ask the FDA to approve the third dose as a booster shot after the first two-shot series has been found to stop neither infection nor virus transmission in a growing percentage of recipients. The FDA said the pfizer-BioNTech shot under the EUA should remain unlicensed but can be used "interchangeably" with the newly licensed Comirnaty product.
According to the FDA: "The licensed vaccine has the same formulation as the EUA-authorized vaccine and the products can be used interchangeably to provide the vaccination series without presenting any safety or effectiveness concerns. The products are legally distinct with certain differences that do not impact safety or effectiveness." However, according to the information Pfizer presented to the ACIP on the safety and efficacy of its Comirnaty vaccine, the company provided the advisory group with efficacy and sequencing data only through March 13 - before the Delta variant became the predominant strain in the U.S., and before studies suggested vaccine effectiveness against the Delta variant could be as low as 42%. In other words, 5.5 months' worth of data was missing from the data Pfizer presented to the ACIP. Previous EUA's for both Pfizer, Moderna, and J&J were greeted with customary public hearings held by the FDA to review the science, allow for public comment before decisions were made, and operate in full transparency. With Pfizer's shot moving to market at record speed with boosters already announced, the lack of promised transparency by the FDA has some worried that the decision was politically driven and may lower standards for future biologics license application approvals.
These are now being administered to millions of people worldwide and even mandated by some countries and institutions. However, due to hundreds of thousands of adverse reactions and tens of thousands of deaths reported to the CDC, VAERS, and other European agencies, not only has the motivation and value for these Covid inoculations come into question, but the ingredients also contained in these experimental jabs have as well. The FDA has not fully evaluated the data and still has not decided if the potential risks outweigh the benefits of receiving it. Human trial data is not complete and published yet, and this is partly why it is considered ‘experimental’ and still unlicensed by the FDA as a biological drug.
Let us be clear, the mRNA inoculations (Pfizer and Moderna) are a synthetic, chimeric pathogenic gene therapy. These have been sequenced from a computer simulation, not an isolated purified model. All the current marketed inoculations: the mRNA, DNA, viral vectored, recombinant protein, viral-like particles, and peptide-based vaccines, use the pathogenic coronavirus’s spike protein in some way or another. (Note: The spike protein of SARS-CoV-2 is made up of two portions, which are S1 and S2. The S1 binds to the ACE2 receptor on the human cell surface, and S2 initiates membrane fusion to complete cell infection.)
Aside from the pathogenic spike protein, recently it has been reported by two Spanish researchers that nanoparticles of graphene oxide (GO) are a component in some analyzed vials of the Pfizer mRNA inoculation. On June 25, the Spanish television show El Gato al Agua, a current affair show hosted by José Javier Esparza, broke the news that “toxic nanoparticulates of graphene oxide have been found in massive quantities in the mRNA Covid 19 vials analyzed by Dr. Pablo Campra Madrid and other biochemists and academics at the University of Almeria”. This was followed up with the initiative of La Quinta Columna, a small group of Spanish researchers headed by Dr. Ricardo Delgado Martin and Dr. José Luis Sevillano, who have been conducting more research on other Pfizer mRNA vials. The Andalusian biostatistician Ricardo Delgado, and his partner Dr. Jose Luis Sevillano (a family doctor,) were intrigued with the observed magnetic phenomenon present in many inoculated with the mRNA fragments. According to these researchers, the graphene oxide nanoparticles when injected into the arm become magnetically influenced as the compound reaches body temperature. Contained at under zero degrees they remain un-magnetic. Allegedly, this is partly why the industry freezes the biological product for storage. They conclude that the magnetic phenomena observed at the inoculation site are due to the graphene oxide nanoparticles included in the Pfizer inoculation.
To be noted in response to La Quinta Columna’s bulletin, Pfizer released a denial that any of its “vaccines” contain graphene oxide. Pharmaceutical-employed ‘Fact Checkers’ quickly followed claiming this assertion was ‘false’. They noted that graphene oxide is not among the ingredients originally listed in Pfizer’s COVID-19 inoculation. The following are the inoculation ingredients Pfizer originally listed with the FDA:
mRNA, lipids ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate), 2 [(polyethylene glycol)-2000]-N, N-ditetradecylacetamide, 1,2-Distearoyl-sn-glycero-3- phosphocholine, and cholesterol), potassium chloride, monobasic potassium phosphate, sodium chloride, dibasic sodium phosphate dihydrate, and sucrose.
Allegedly, these Spanish researchers’ analyses included microscopy, spectroscopy, and other laboratory techniques. They continue to analyze other Covid 19 inoculation vials and intend to make public their findings. (See the video Graphene Oxide: A way to kill and control under References.) Again, graphene oxide nanoparticles were not originally disclosed as an ingredient in any of the patents of the mRNA biological agents submitted to the FDA. Thus, these graphene oxide nanoparticles are to date an undisclosed additive and maybe a ‘proprietary ingredient’. Another explanation is that they may not have originally included these graphene nanoparticles, but reportedly now do in some of the lots.
Following this bombshell disclosure, Karen Kingston, a former Pfizer employee and current analyst for the pharmaceutical and medical device industries, has also publicly stated that graphene oxide is present in the Covid inoculations. “It’s extremely difficult to find this information,” she said on the Stew Peters Show. https://stewpeters.podbean.com/) When asked by Peters if graphene oxide was present in the corona vaccines, she replied unequivocally: “100 percent, that’s irrefutable.” Kingston suspects that graphene oxide is not listed in the patent applications because a), it is poisonous to humans and b), because it is the main ingredient in the hydrogel which can be used to create a brain-computer interface and as a drug delivery system. Kingston notes that brain-computer interface is not possible “with this round [of vaccines]” because “they rushed this thing out” and “they’re just seeing how much they can put into people before they… die”
The former Pfizer employee further explained that the graphene oxide in the inoculations is neutrally charged (inactive), however, if/when it becomes positively charged, such as by electromagnetic radiation (radio frequency, such as wireless devices, wireless networks such as 5G, etc.), it can cause neurological damage and death depending on how much of it exists in the body and where it is located. Therefore, according to Kingston, multiple COVID-19 inoculations and booster shots are needed to gradually increase the amount of graphene oxide in the body to make the body receptive to electromagnetic radiation.
All these claims have raised serious concerns, particularly in the world of toxicology. We simply do not know the whole story yet, nor if other COVID inoculations may contain graphene oxide. What we do know is in 2020 two Chinese Covid vaccine patents were filed that list graphene as an ingredient. The first Chinese patented listed a ‘nano coronavirus recombinant vaccine using graphene oxide as a carrier’.1 The second listed the ‘preparation and application of pachyman nano adjuvant based on graphene oxide and adjuvant/antigen co-delivery vaccine’.2 Thus, it is certainly not beyond the realm of possibility that Pfizer has included GO in some of its lots of Covid inoculations.
This article is primarily intended to clarify some of the toxicology concerns associated with graphene oxide used as an injectable as well as illuminate some of the potential reasons for its alleged employment in inoculations and other medical applications. Many questions have arisen around this potentially toxic substance being injected into millions of people worldwide. Firstly, for what reason is this toxic substance included in the experimental Pfizer Covid 19 mRNA formula? One above-the-rabbit hole explanation is that it is an antimicrobial additive. It has been reported in numerous studies that carbon-based technologies such as carbon nanotubes, graphene, graphene oxide, and quantum dots are antimicrobial and can inactivate viruses.3, 4, 5, 6
Graphene’s antimicrobial properties were initially published in 2014 by Sametband et al. who used graphene oxide (GO) derivatives to inhibit HSV-1 via viral attachment blocking. The GO blocked HSV-1 infections at relatively low concentrations and the charge density was the major factor affecting the inhibition of the virus.7 According to subsequent research these carbon-based materials are candidates for anti-viral applications that can inhibit viruses by a variety of mechanisms, including photothermal or reactive oxygen species production.
Recently, GO has also been used commercially in ‘antimicrobial’ coatings on face masks and even as ‘immunosensors’ in diagnostic kits. Surgical masks produced by Shandong Shenquan New Materials were taken off the market in Spain by the national health authority, Sanidad last April, due to the discovery of graphene oxide. Thus, it has also been disclosed that graphene particles are currently employed in various medical devices and equipment such as diagnostic kits, anti-viral coatings, face masks, and shields for alleged protection of microorganisms and disinfection. Even more disturbing, there have been reports of food being contaminated with graphene particles. Some have even claimed that the chemicals being sprayed through climate geoengineering also include graphene.
Hence, it is not a surprise that researchers have claimed to have found graphene oxide nanoparticles in the Pfizer COVID inoculation vials. The official explanation, if there ever is one, will probably be that it is a “necessary antiviral component or delivery device”. Other explanations further down the rabbit hole have been forthcoming and involve more nefarious purposes. Before disclosing those concerns, let us discuss more details about graphene oxide and graphene-related nanomaterials (GFN). The background of its applications is necessary to understand why and how it can be used on humans.
After the first demonstration of graphene nanoparticles isolation by Geim and Novoselov, from bulk graphite in 2004, graphene and its derivatives have been widely used in different sectors of the industry and particularly the medical industry.8 Today, graphene oxide and graphene-related nanomaterials (GFN) are extensively used in biomedical applications, such as biosensors, antimicrobials, cell imaging, drug delivery, and tissue engineering.9, 10, 11
A second explanation is that it may be used as a biosensor and can potentially enhance human physiology to become more receptive to electromagnetic fields, particularly 5 G microwave radiation. GO is a fluorescent material and can be used for biosensing applications for early disease detection and detecting biologically relevant molecules. Graphene oxide mixes readily with many polymers, forming nanocomposites, while greatly enhancing the properties of the original polymer, including elastic modulus, tensile strength, electrical conductivity, and thermal stability.For biosensing applications, it can be easily complexed with biomolecules as graphene oxide is covered with different functionalities such as epoxy, hydroxyl, and carboxylic groups.
Thus, commercially, GO is already being used in fluorescent-based biosensors for the detection of DNA and proteins as well as in neuromodulation devices. For example, this is a news release by INBRAIN Neuroelectronics S.L about their intention to use graphene as a biosensor for neuromodulation:
“INBRAIN Neuroelectronics S.L. is a medical device company dedicated to the development and commercialization of graphene-based neural interfaces and intelligent neuromodulation systems. Founded in 2019, the company is a spin-off from Graphene Flagship partners, Catalan Institute of Nanoscience and Nanotechnology (ICN2) & ICREA in Barcelona. INBRAIN is developing the least invasive and most intelligent neural interface on the market that will be able to read and modulate brain activity with very high resolution to obtain optimal results in personalized neurological therapies. INNERVIA Bioelectronics, is a subsidiary of INBRAIN Neuroelectronics, is dedicated to the development and commercialization of intelligent graphene systems designed to modulate vagus nerve signals, decoding them into medical solutions.” (For more information, please visit inbrain-neuroelectronics.com.)
Graphene Oxide and Graphene-related Nanomaterials (GFN) Properties
Graphene is light, flexible, and transparent and both electrically and thermally highly conductive, which opens the possibility of using it in a broad spectrum of applications, including supercapacitors. Graphene-based materials usually have sizes ranging from several to hundreds of nanometers and are 1-10 nm thick, which also meets the definition of nanoparticles or nanomaterials.
What we commonly refer to as (permanent) magnetism is more properly called ferromagnetism. It is the property of a material such as iron (hence ‘ferro’), nickel, or cobalt to become magnetized in the presence of an external magnet or magnetic field with the magnetism persisting after the external field is removed.
Paramagnetism refers to the property of a material to become magnetic in the presence of an external magnet or magnetic field. This is an induced magnetism that persists only if the external magnetic field is applied. The strength of paramagnetism is proportional to the strength of the applied magnetic field. An additional type of magnetism exhibited by some synthetic materials is super-paramagnetism. It is a more complex property but is defined as having a net paramagnetic response yet displaying ferromagnetic or ferrimagnetic ordering at the microscopic level.
The key point is that graphene oxide contains no ferromagnetic material such as iron, but due to its paramagnetic property can still be magnetized if an external magnet is in its presence. This may explain the numerous anecdotally observed effects of magnets sticking to the injection site of some individuals.
Graphene’s Use in Industry and Medicine
Since the discovery of graphene, applications within different scientific disciplines have exploded, with huge gains being made particularly in high-frequency electronics, biochemical and magnetic sensors, ultra-wide bandwidth photodetectors, and energy storage and generation.
Graphene oxide (GO) is the oxidized form of the graphene family of nanomaterials (GFN). Graphene oxide (GO) and reduced graphene oxide (rGO), as previously mentioned, are materials used in numerous applications and fields. The key difference between graphene oxide and reduced graphene oxide is that the graphene oxide contains oxygen-containing functional groups whereas the reduced graphene oxide lacks the oxygen-containing functional groups.
Due to their extremely high surface area, these materials are considered excellent for usage as electrode materials in batteries, and double-layered capacitors, as well as fuel cells and solar cells. Thus, GFN is extensively used in energy storage, nano-electronic devices, batteries and for redox enzyme encapsulation to improve electron communication between enzymes and electrodes.12
The interest in using graphene-related nanomaterials (GFN) in medicine lies chiefly upon the extraordinary properties of graphene, including its mechanical properties, flexibility, transparency, and thermo-electrical conductivity.13 The holdup has been its biological toxicity. Despite its known toxicity, researchers have already started exploring the use of graphene on the central nervous system for cell labeling and real-time live-cell monitoring. This allows delivery to the brain of molecules (chimeric mRNA) that are usually rejected by the blood-brain barrier as GFN easily penetrates this and other membrane barriers. In addition, interfacing graphene with neural cells was also proposed to be extremely advantageous for exploring their electrical behavior or facilitating neuronal regeneration by promoting controlled elongation of neuronal processes. These applications open new applications in neuro-therapeutics or manipulation.
The large surface area available and the possibility of conjugating different molecules onto its surface, make graphene an excellent material for holding and carrying drugs, genes (including siRNA and mRNA), antibodies, and proteins (viral/microbial) into the body.
The functionalization of GO also reduces the agglomeration. So far, certain nucleic acids, peptides, and proteins have been used to ‘functionalize’ graphene oxide as a biosensor. In short, GO has potential for use in biosensors because of its unique characteristics such as facile surface modification, high mechanical strength, good water dispersibility, and photoluminescence.13, 14, 15, 16
Graphene can also be exploited as a substrate for tissue engineering. In this case, conductivity is probably the most relevant amongst the various properties of the different graphene materials, as it may allow to instruct and interrogate neural networks, as well as to drive neural growth and differentiation. An example of how this material may be used neurologically is front and center to the corporation Neuralink. The Neuralink Corporation is a neurotechnology company developing implantable brain-machine interfaces (BMIs) and was founded by Elon Musk and others. Musk defined the neural lace as a "digital layer (composed of graphene) above the cortex" that would not necessarily imply extensive surgical insertion but ideally an implant through a vein or artery (as from an inoculation jab). Musk explained that the long-term goal is to achieve "symbiosis with artificial intelligence".
Additionally, GO has been demonstrated commercially in different biosensing applications, for early disease detection, and detecting biologically relevant molecules. Thus, other researchers claim that because GO is an effective biosensor. Once injected, these particles can be utilized to monitor the biological environment, such as microorganisms and other specific blood elements.
Down and Up the Rabbit Hole